$SFCC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PharmaNet Development Group Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PharmaNet Development Group Inc. Get notifications about new insider transactions in PharmaNet Development Group Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2007 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Sell | S | 26.10 | 370 | 9,657 | 7,431 | 7.8 K to 7.4 K (-4.74 %) |
| Mar 08 2007 | SFCC | PharmaNet Developm ... | LEBEL MARC | EVP Bioanalytical L ... | Sell | S | 24.06 | 5,100 | 122,706 | 48,002 | 53.1 K to 48 K (-9.60 %) |
| Mar 07 2007 | SFCC | PharmaNet Developm ... | LEBEL MARC | EVP Bioanalytical L ... | Sell | S | 23.40 | 14,900 | 348,660 | 53,102 | 68 K to 53.1 K (-21.91 %) |
| Jan 08 2007 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Sell | D | 21.50 | 445 | 9,568 | 7,801 | 8.2 K to 7.8 K (-5.40 %) |
| Jan 08 2007 | SFCC | PharmaNet Developm ... | LUCKING DAVID | Director | Sell | D | 21.50 | 886 | 19,049 | 43,110 | 44 K to 43.1 K (-2.01 %) |
| Jan 08 2007 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Sell | D | 21.50 | 1,034 | 22,231 | 16,160 | 17.2 K to 16.2 K (-6.01 %) |
| Jan 08 2007 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Sell | D | 21.50 | 757 | 16,276 | 45,112 | 45.9 K to 45.1 K (-1.65 %) |
| Jul 05 2006 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | President and CEO | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
| Jul 05 2006 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | President and CEO | Grant | A | 15.16 | 62,461 | 946,909 | 131,661 | 69.2 K to 131.7 K (+90.26 %) |
| Aug 28 2006 | SFCC | PharmaNet Developm ... | LUCKING DAVID | Director | Grant | A | 17.25 | 7,246 | 124,994 | 43,996 | 36.8 K to 44 K (+19.72 %) |
| Aug 28 2006 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Grant | A | 17.25 | 7,246 | 124,994 | 15,546 | 8.3 K to 15.5 K (+87.30 %) |
| Aug 28 2006 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Grant | A | 17.25 | 11,014 | 189,992 | 41,014 | 30 K to 41 K (+36.71 %) |
| Aug 28 2006 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Grant | A | 17.25 | 7,246 | 124,994 | 8,246 | 1,000 to 8.2 K (+724.60 %) |
| May 17 2006 | SFCC | PharmaNet Developm ... | NATAN DAVID | Chief Financial Off ... | Grant | A | 18.30 | 15,000 | 274,500 | 19,978 | 5 K to 20 K (+301.33 %) |
| May 16 2006 | SFCC | PharmaNet Developm ... | LEBEL MARC | Executive VP of Lab ... | Buy | P | 15.86 | 7,400 | 117,364 | 68,002 | 60.6 K to 68 K (+12.21 %) |
| May 16 2006 | SFCC | PharmaNet Developm ... | LEBEL MARC | Executive VP of Lab ... | Buy | P | 15.48 | 7,500 | 116,100 | 60,602 | 53.1 K to 60.6 K (+14.12 %) |
| May 16 2006 | SFCC | PharmaNet Developm ... | LEBEL MARC | Executive VP of Lab ... | Grant | A | 23.35 | 10,000 | 233,500 | 53,102 | 43.1 K to 53.1 K (+23.20 %) |
| May 16 2006 | SFCC | PharmaNet Developm ... | LEBEL MARC | Executive VP of Lab ... | Grant | A | 18.30 | 15,000 | 274,500 | 43,102 | 28.1 K to 43.1 K (+53.38 %) |
| Feb 02 2006 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
| Feb 02 2006 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Grant | A | 0.00 | 20,000 | 0 | 35,000 | 15 K to 35 K (+133.33 %) |
| Nov 28 2005 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Buy | P | 22.43 | 1,000 | 22,430 | 6,000 | 5 K to 6 K (+20.00 %) |
| Nov 22 2005 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Buy | P | 22.27 | 800 | 17,816 | 800 | 0 to 800 |
| Nov 15 2005 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Buy | P | 32.32 | 1,000 | 32,320 | 1,000 | 0 to 1,000 |
| Nov 21 2005 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Buy | P | 26.47 | 2,000 | 52,940 | 5,000 | 3 K to 5 K (+66.67 %) |
| Nov 18 2005 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Buy | P | 27.69 | 1,000 | 27,690 | 4,000 | 3 K to 4 K (+33.33 %) |
| Nov 10 2005 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Buy | P | 31.29 | 2,000 | 62,580 | 5,000 | 3 K to 5 K (+66.67 %) |
| Nov 08 2005 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Buy | P | 30.10 | 1,000 | 30,100 | 3,250 | 2.3 K to 3.3 K (+44.44 %) |
| Nov 08 2005 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Buy | P | 28.85 | 2,000 | 57,700 | 3,000 | 1,000 to 3 K (+200.00 %) |
| Nov 08 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | Chief Financial Off ... | Buy | P | 30.88 | 1,000 | 30,880 | 4,978 | 4 K to 5 K (+25.14 %) |
| Nov 08 2005 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Buy | P | 30.22 | 3,000 | 90,660 | 3,000 | 0 to 3 K |
| Nov 07 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Option Exercise | M | 11.18 | 11,000 | 122,980 | 15,000 | |
| Nov 07 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Buy | M | 11.18 | 11,000 | 122,980 | 14,000 | 3 K to 14 K (+366.67 %) |
| Sep 22 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Option Exercise | M | 11.18 | 3,000 | 33,540 | 26,000 | |
| Sep 22 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Buy | M | 11.18 | 3,000 | 33,540 | 3,000 | 0 to 3 K |
| Sep 13 2005 | SFCC | PharmaNet Developm ... | LEBEL MARC | Senior Vice Preside ... | Sell | S | 43.55 | 7,500 | 326,625 | 28,102 | 35.6 K to 28.1 K (-21.07 %) |
| Aug 08 2005 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Option Exercise | M | 17.20 | 37,500 | 645,000 | 159,390 | |
| Aug 08 2005 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Buy | M | 17.20 | 37,500 | 645,000 | 226,743 | 189.2 K to 226.7 K (+19.82 %) |
| Aug 08 2005 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Payment of Exercise | F | 0.00 | 15,636 | 0 | 189,243 | 204.9 K to 189.2 K (-7.63 %) |
| Aug 05 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Option Exercise | M | 11.18 | 4,000 | 44,720 | 29,000 | |
| Aug 05 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Sell | S | 40.76 | 4,000 | 163,040 | 0 | 4 K to 0 (-100.00 %) |
| Aug 05 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Buy | M | 11.18 | 4,000 | 44,720 | 4,000 | 0 to 4 K |
| Jul 01 2005 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Option Exercise | A | 38.63 | 15,000 | 579,450 | 127,500 | |
| Jul 05 2005 | SFCC | PharmaNet Developm ... | LUCKING DAVID | Director | Option Exercise | A | 38.63 | 15,000 | 579,450 | 60,000 | |
| Jul 01 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Option Exercise | A | 38.63 | 15,000 | 579,450 | 33,000 | |
| May 19 2005 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres & Chief Exec O ... | Option Exercise | A | 38.00 | 24,593 | 934,534 | 263,393 | |
| May 19 2005 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Option Exercise | A | 38.00 | 32,520 | 1,235,760 | 221,820 | |
| May 19 2005 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Grant | A | 0.00 | 15,913 | 0 | 670,143 | 654.2 K to 670.1 K (+2.43 %) |
| May 19 2005 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Option Exercise | A | 38.00 | 32,520 | 1,235,760 | 206,820 | |
| May 19 2005 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Grant | A | 0.00 | 15,913 | 0 | 322,029 | 306.1 K to 322 K (+5.20 %) |
| May 19 2005 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Option Exercise | A | 38.00 | 24,390 | 926,820 | 196,890 | |
| May 19 2005 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Grant | A | 0.00 | 11,935 | 0 | 192,945 | 181 K to 192.9 K (+6.59 %) |
| May 19 2005 | SFCC | PharmaNet Developm ... | LEBEL MARC | Senior Vice Preside ... | Option Exercise | A | 38.00 | 8,943 | 339,834 | 106,443 | |
| May 19 2005 | SFCC | PharmaNet Developm ... | LEBEL MARC | Senior Vice Preside ... | Grant | A | 0.00 | 4,376 | 0 | 35,602 | 31.2 K to 35.6 K (+14.01 %) |
| May 19 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | Chief Financial Off ... | Option Exercise | A | 38.00 | 8,130 | 308,940 | 24,380 | |
| May 19 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | Chief Financial Off ... | Grant | A | 0.00 | 3,978 | 0 | 3,978 | 0 to 4 K |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Sell | S | 38.00 | 125,000 | 4,750,000 | 306,116 | 431.1 K to 306.1 K (-28.99 %) |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Option Exercise | A | 24.37 | 3,250 | 79,203 | 14,750 | |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Option Exercise | M | 7.03 | 3,000 | 21,090 | 1,500 | |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Option Exercise | M | 11.37 | 12,750 | 144,968 | 0 | |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Sell | S | 38.00 | 19,000 | 722,000 | 0 | 19 K to 0 (-100.00 %) |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Buy | M | 24.37 | 3,250 | 79,203 | 19,000 | 15.8 K to 19 K (+20.63 %) |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Buy | M | 7.03 | 3,000 | 21,090 | 15,750 | 12.8 K to 15.8 K (+23.53 %) |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Buy | M | 11.37 | 12,750 | 144,968 | 12,750 | 0 to 12.8 K |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Sell | S | 38.00 | 250,000 | 9,500,000 | 654,230 | 904.2 K to 654.2 K (-27.65 %) |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | LEBEL MARC | President of Subsid ... | Sell | S | 38.00 | 26,000 | 988,000 | 31,226 | 57.2 K to 31.2 K (-45.43 %) |
| Jan 10 2005 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Option Exercise | A | 7.03 | 60,000 | 421,800 | 0 | |
| Jan 10 2005 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Payment of Exercise | F | 38.64 | 10,916 | 421,794 | 181,010 | 191.9 K to 181 K (-5.69 %) |
| Jan 10 2005 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Buy | M | 7.03 | 60,000 | 421,800 | 191,926 | 131.9 K to 191.9 K (+45.48 %) |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Option Exercise | M | 11.18 | 2,000 | 22,360 | 18,000 | |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Sell | S | 38.00 | 2,000 | 76,000 | 0 | 2 K to 0 (-100.00 %) |
| Mar 17 2005 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Buy | M | 11.18 | 2,000 | 22,360 | 2,000 | 0 to 2 K |
| Nov 15 2004 | SFCC | PharmaNet Developm ... | LEBEL MARC | President of Subsid ... | Sell | S | 35.60 | 7,500 | 267,000 | 15,375 | 22.9 K to 15.4 K (-32.79 %) |
| Nov 10 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Option Exercise | M | 11.18 | 15,000 | 167,700 | 20,000 | |
| Nov 10 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Sell | S | 34.04 | 10,000 | 340,400 | 0 | 10 K to 0 (-100.00 %) |
| Nov 10 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Sell | S | 34.84 | 5,000 | 174,200 | 10,000 | 15 K to 10 K (-33.33 %) |
| Nov 10 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Buy | M | 11.18 | 15,000 | 167,700 | 15,000 | 0 to 15 K |
| Jul 29 2004 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Option Exercise | A | 27.23 | 75,000 | 2,042,250 | 174,300 | |
| Aug 03 2004 | SFCC | PharmaNet Developm ... | LEBEL MARC | President of Subsid ... | Sell | S | 33.92 | 7,500 | 254,400 | 22,875 | 30.4 K to 22.9 K (-24.69 %) |
| Jul 29 2004 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Option Exercise | A | 27.23 | 75,000 | 2,042,250 | 189,300 | |
| Jun 28 2004 | SFCC | PharmaNet Developm ... | LEBEL MARC | President of Subsid ... | Sell | S | 29.06 | 7,500 | 217,950 | 94,653 | 102.2 K to 94.7 K (-7.34 %) |
| Jun 24 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Option Exercise | M | 11.18 | 10,000 | 111,800 | 22,000 | |
| Jun 24 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Sell | S | 26.32 | 10,000 | 263,200 | 0 | 10 K to 0 (-100.00 %) |
| Jun 24 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Buy | M | 11.18 | 10,000 | 111,800 | 10,000 | 0 to 10 K |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Option Exercise | M | 11.37 | 112,500 | 1,279,125 | 0 | |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Payment of Exercise | F | 24.33 | 52,574 | 1,279,125 | 131,926 | 184.5 K to 131.9 K (-28.50 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Buy | M | 11.37 | 112,500 | 1,279,125 | 184,500 | 72 K to 184.5 K (+156.25 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Option Exercise | M | 7.03 | 1,500 | 10,545 | 4,500 | |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Option Exercise | M | 11.37 | 6,000 | 68,220 | 12,750 | |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Sell | S | 23.75 | 7,500 | 178,125 | 0 | 7.5 K to 0 (-100.00 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Buy | M | 7.03 | 1,500 | 10,545 | 7,500 | 6 K to 7.5 K (+25.00 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Buy | M | 11.37 | 6,000 | 68,220 | 6,000 | 0 to 6 K |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Option Exercise | M | 4.40 | 150,000 | 660,000 | 0 | |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Sell | S | 23.75 | 72,873 | 1,730,734 | 904,230 | 977.1 K to 904.2 K (-7.46 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Payment of Exercise | F | 24.33 | 27,127 | 660,000 | 977,103 | 1 M to 977.1 K (-2.70 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | KRINSKY LISA MD | President | Buy | M | 4.40 | 150,000 | 660,000 | 1,004,230 | 854.2 K to 1 M (+17.56 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Option Exercise | M | 4.40 | 75,000 | 330,000 | 0 | |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Sell | S | 23.75 | 36,436 | 865,355 | 431,116 | 467.6 K to 431.1 K (-7.79 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Payment of Exercise | F | 24.33 | 13,564 | 330,012 | 467,552 | 481.1 K to 467.6 K (-2.82 %) |
| Jun 03 2004 | SFCC | PharmaNet Developm ... | HANTMAN ARNOLD | Chief Executive Off ... | Buy | M | 4.40 | 75,000 | 330,000 | 481,116 | 406.1 K to 481.1 K (+18.47 %) |
| May 12 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Option Exercise | M | 6.55 | 1,600 | 10,480 | 32,000 | |
| May 12 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Sell | S | 37.01 | 600 | 22,206 | 0 | 600 to 0 (-100.00 %) |
| May 12 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Sell | S | 0.00 | 1,000 | 0 | 600 | 1.6 K to 600 (-62.50 %) |
| May 12 2004 | SFCC | PharmaNet Developm ... | DR WEINSTEIN LEONARD L | Director | Buy | M | 6.55 | 1,600 | 10,480 | 1,600 | 0 to 1.6 K |
| Apr 30 2004 | SFCC | PharmaNet Developm ... | NATAN DAVID | VP-Finance (CFO) | Option Exercise | A | 36.55 | 12,000 | 438,600 | 12,000 | |
| Apr 30 2004 | SFCC | PharmaNet Developm ... | LEBEL MARC | President of Subsid ... | Option Exercise | A | 36.55 | 30,000 | 1,096,500 | 30,000 | |
| Apr 30 2004 | SFCC | PharmaNet Developm ... | INGENITO GARY | Senior Vice Preside ... | Option Exercise | A | 36.55 | 18,000 | 657,900 | 18,000 | |
| Apr 30 2004 | SFCC | PharmaNet Developm ... | HOLMES DR GREGORY B | Executive Vice Pres ... | Option Exercise | A | 36.55 | 90,000 | 3,289,500 | 90,000 |